摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1-(di-tert-butylphosphino)-3-tert-butylimidazol-2-ylidene) | 1354579-06-8

中文名称
——
中文别名
——
英文名称
(1-(di-tert-butylphosphino)-3-tert-butylimidazol-2-ylidene)
英文别名
1-tert-butyl-3-[di(tert-butyl)phosphanyl]imidazol-2-ylidene;1-(di(tert-butyl)phosphanyl)-3-tert-butyl-imidazolylidene;ditert-butyl-(3-tert-butyl-2H-imidazol-3-ium-2-id-1-yl)phosphane
(1-(di-tert-butylphosphino)-3-tert-butylimidazol-2-ylidene)化学式
CAS
1354579-06-8
化学式
C15H29N2P
mdl
——
分子量
268.382
InChiKey
IGVCKKZKFOOXEB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    6.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    (1-(di-tert-butylphosphino)-3-tert-butylimidazol-2-ylidene)氘代苯 为溶剂, 反应 1.0h, 以98%的产率得到1-tert-butyl-2-[di(tert-butyl)phosphanyl]-1H-imidazole
    参考文献:
    名称:
    Direct synthesis of N-phosphanyl-heterocyclic carbenes
    摘要:
    A direct method for the synthesis of N-phosphanyl-heterocyclic carbenes is described. The method is based on the reaction of lithium imidazolides and benzimidazolides having a bulky alkyl group at the nitrogen atom with di(tert-butyl)chlorophosphine leading directly to the carbenes. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2011.11.054
  • 作为产物:
    参考文献:
    名称:
    庞大的N-膦基官能化N-杂环碳烯配体:烯烃复分解的合成,钌配位化学和钌亚烷基络合物
    摘要:
    介绍了钌化学及其在基于N-膦基官能化的N-杂环卡宾配体(NHCP)的催化烯烃复分解中的应用。描述了烷基NHCP Ru的配位化学,并概述了将三甲基甲硅烷基和苯基亚烷基结合到钌亚烷基络合物的几种潜在合成前体中的方法。Ru亚烷基络合物被评估为潜在的烯烃复分解催化剂,并表现出潜在的性能。它们在升高的温度下显示出对于闭环易位和开环易位聚合的催化活性。
    DOI:
    10.1021/acs.inorgchem.5b00513
点击查看最新优质反应信息

文献信息

  • Synthesis and Structures of Copper(I) Complexes with Phosphino-Functionalized N-Heterocyclic Carbenes (NHCP) and Bis-N-Heterocyclic Carbenes (Bis-NHC)
    作者:Erik Kühnel、Igor V. Shishkov、Frank Rominger、Thomas Oeser、Peter Hofmann
    DOI:10.1021/om300701u
    日期:2012.11.26
    New copper(I) complexes bearing N-phosphino- and N-phosphinomethyl-functionalized NHC ligands (NHCP systems) were synthesized and fully characterized. Using halide-containing copper(I) precursors, strikingly different structural motifs were found, dependent on the substitution pattern of the NHCP moiety. An interesting tetranuclear μ4-bridged copper(I) cluster (4b) is formed when CuBr·SMe2 is reacted
    合成并充分表征了带有N-膦基和N-膦基甲基官能化的NHC配体的新型(I)配合物。使用含卤化物的(I)前体,发现了完全不同的结构基序,具体取决于NHCP部分的取代方式。一个有趣的四核μ 4 -bridged(I)群集(图4b)时的CuBr·SMe的形成2与反应Ñ膦基取代的配体1A而双核配合物,图4a与类似的反应中形成1b中。双核属环(2a,b)分离并通过X射线衍射对无卤化(I)前体[Cu(CH 3 CN)4 ] PF 6与NHCP配体1a,b使用N-膦酰基甲基取代的NHCP配体5a,b,以及分别使用双-NHC配体BIM和BIM-BMe 2(10a,b)。所观察到的(I)-(I)距离与所形成的属环的大小直接相关。在10a,b中发现带电配合物对属-属分离有意想不到的强烈影响。直接使用Nt个步取代的配位体NHCP导致在(I)中心(形成一个电子不太有利的反式- C,C协调3和图
  • Preparation and reactivity of a Ru(0) phosphino–carbene complex
    作者:Eliar Mosaferi、Li Pan、Tongen Wang、Yunshan Sun、Conor Pranckevicius、Douglas W. Stephan
    DOI:10.1039/c5dt04337a
    日期:——
    The reaction of the phosphino–carbene MeNC3H2NPtBu2 with RuHCl(CO)(PPh3)3 is shown to give facile access to the Ru(0) species (MeNC3H2NPtBu2)Ru(CO)(PPh3)2 (1). This species undergoes oxidative addition of H2 and silanes to give (MeNC3H2NPtBu2)RuH2(CO)(PPh3)24, (MeNC3H2NPtBu2)Ru H(SiRPh2)(CO)(PPh3) (R = Ph 5, H 6) and (MeNC3H2NPtBu2) RuH(PhSi(SCH2CH2)2O)(CO)(PPh3) 7.
    膦-卡宾MeNC 3 H 2 NP t Bu 2与RuHCl(CO)(PPh 3)3的反应表明,可以轻松地访问Ru(0)物种(MeNC 3 H 2 NP t Bu 2)Ru( CO)(PPh 3)2(1)。该物质经过H 2和硅烷的氧化加成,得到(MeNC 3 H 2 NP t Bu 2)RuH 2(CO)(PPh 3)2 4,(MeNC 3H 2 NP t Bu 2)Ru H(SiRPh 2)(CO)(PPh 3)(R = Ph 5,H 6)和(MeNC 3 H 2 NP t Bu 2)RuH(PhSi(SCH 2 CH 2)2 O)(CO)(PPh 3)7。
  • <i>N</i>-Phosphanyl- and <i>N</i>,<i>N</i>′-Diphosphanyl-Substituted N-Heterocyclic Carbene Chromium Complexes: Synthesis, Structures, and Catalytic Ethylene Oligomerization
    作者:Pengfei Ai、Andreas A. Danopoulos、Pierre Braunstein
    DOI:10.1021/acs.organomet.5b00547
    日期:2015.8.24
    The chromium(II) complexes [CrCl2(t-BuNHC,P-kappa C)(2)] (1), [CrCl2((NHC)-N-Mes,P-kappa C)(2)] (2), [CrCl2((NHC)-N-Dipp,P-kappa C)(2)] (3), and [CrCl2(P,NHC,P-kappa C)(2)] (4) containing the N-phosphanyl- or N,N'-diphosphanyl-substituted N-heterocyclic carbene (NHC) hybrid ligands t-BuNHC,P (1-(di-tert-butylphosphino)-3-tert-butylimidazol-2-ylidene), (NHC)-N-Mes,P (1-(di-tert-butylphosphino)-3-mesitylimidazol-2-ylidene), (NHC)-N-Dipp,P (1-(di-tert-butylphosphino)-3-(2,6-diisopropylphenyl)imidazol-2-ylidene), and P,NHC,P (1,3-bis(di-tert-butylphosphino)imidazol-2-ylidene), respectively, were prepared from Cr-II ([CrCl2(thf)(2)]) or Cr-III ([CrCl3(thf)(3)] or [Cr(Me)Cl-2(thf)(3)]) precursors. The solid-state structures of these four complexes show square-planar Cr-II centers, with two trans chloride and two monodentate C-NHC donors. Alkylation of 3 and 4 with [Mg(benzyl)(2)(thf)(2)] led to the formation of the sigma complexes [Cr(benzyl)(3)((NHC)-N-Dipp,P-kappa C,kappa P)] (5) and [Cr(benzyl)(3)(P,NHC,P-kappa C,kappa P)] (6), respectively, with five-coordinate distorted-square-pyramidal Cr-III coordination, comprising a chelating ligand through the C-NHC and one P donor and three benzyl groups. These complexes were used as precatalysts in ethylene oligomerization, and it was found that the nature of the cocatalyst used and the metal oxidation state have a remarkable influence on the catalytic properties. The Cr-III/MAO systems displayed superior catalytic performance (TOF values up to 16320 mol of C2H4/((mol of Cr) h) for 6) and gave mostly oligomers. Interestingly, the oligomers obtained with complex 3 were almost exclusively 1-hexene and 1-butene when the reaction was initiated at 30 degrees C. The overall activities and selectivities were also affected by the initial reaction temperature and the nature of the solvent. With AlEtCl2 (EADC) as cocatalyst, polyethylene was predominately formed.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)